{
  "docId": "019de516-de84-709f-9864-0c2e708269aa",
  "docSlug": "d2a0e3b4a50bc196c7afb3f2c93e5906",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 38 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 38,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-de84-709f-9864-0c2e708269aa/16",
  "deckHref": "/decks/019de516-de84-709f-9864-0c2e708269aa",
  "deckJsonHref": "/decks/019de516-de84-709f-9864-0c2e708269aa.json",
  "deckAnchorHref": "/decks/019de516-de84-709f-9864-0c2e708269aa#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.259,
        "w": 0.365,
        "x": 0.045,
        "y": 0.392
      },
      "kind": "image",
      "text": "WELCOME TEAM Xiidra (lifitegrast ophthalmic solution)5%",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "abfe5bd2-ec49-4844-9c52-ad55e32b44e6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.157,
        "w": 0.176,
        "x": 0.08,
        "y": 0.201
      },
      "kind": "image",
      "text": "Xiidra (lifitegrast ophthalmic solution)5%",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47c1ee90-a67d-4550-ba66-757d959ed5a3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.259,
        "w": 0.365,
        "x": 0.045,
        "y": 0.659
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b03fdf7e-1df7-4ad9-8f98-983c9fb48897",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.404,
        "x": 0.525,
        "y": 0.648
      },
      "kind": "list",
      "text": "Competitive formulary coverage and proven market access track record",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "28474b8c-0d4c-4cb8-9b3e-e06a61f0ed1a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.259,
        "x": 0.326,
        "y": 0.207
      },
      "kind": "list",
      "text": "Specifically approved to treat signs and symptoms of DED, focusing on inflammation associated with dry eye",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2af02870-5c72-4d21-b572-a7974f49c0ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.404,
        "x": 0.525,
        "y": 0.756
      },
      "kind": "list",
      "text": "Strong intellectual property portfolio, generics settlements reached for Q2 2032 entry",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2feb5b72-2f7d-4e11-8822-f4f8cb9a37cb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.13,
        "w": 0.279,
        "x": 0.64,
        "y": 0.207
      },
      "kind": "list",
      "text": "Completed acquisition of Xiidra in September 2023, focused on transition in Q4 2023 and relaunch",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3fd56e10-b33f-42bb-8a48-98d33efb0763",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.404,
        "x": 0.525,
        "y": 0.54
      },
      "kind": "list",
      "text": "Well established – Xiidra is a leading DED branded Rx product in the market",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f10fbba-fe6d-48d8-93ee-f4bbc8790da2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.404,
        "x": 0.525,
        "y": 0.432
      },
      "kind": "list",
      "text": "Differentiated clinical profile – Signs and symptoms of DED focusing on inflammation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c6eef81c-5bf3-40c8-a8cb-7a4db576dc82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.013,
        "w": 0.129,
        "x": 0.045,
        "y": 0.949
      },
      "kind": "source-note",
      "text": "BAUSCH+LOMB",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e29cb892-731c-45ac-bb08-9c94753c72a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.899,
        "x": 0.045,
        "y": 0.08
      },
      "kind": "title",
      "text": "Completed Xiidra Acquisition, Transformed Pharmaceuticals Business",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd46805c-59ac-48dc-a706-b5defdc6e2d8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 13,
      "beatId": "d76085c2-7614-4652-81f9-fe73baff9b13",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The deck outlines strategic initiatives to drive growth momentum.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 17,
      "from": 14,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "6190ac6f-cdb0-4539-ab6e-48d558874b1d",
      "evidence": "The deck highlights the importance of taking action to strengthen supply chain.",
      "position": 1,
      "objective": "What are the consequences of not taking action to strengthen supply chain?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}